DMARDS and infections in rheumatoid arthritis
- 9 June 2008
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 8 (2), 139-143
- https://doi.org/10.1016/j.autrev.2008.05.001
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritisCurrent Opinion in Rheumatology, 2008
- Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsAnnals Of The Rheumatic Diseases, 2007
- Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritisRheumatology, 2007
- Glucocorticoid use, other associated factors, and the risk of tuberculosisArthritis Care & Research, 2006
- Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease‐modifying antirheumatic drugs, and anti–tumor necrosis factor therapyArthritis & Rheumatism, 2006
- The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion moleculesClinical Immunology, 2005
- Co-morbidity in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2003
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.Annals Of The Rheumatic Diseases, 1990
- Infection in Rheumatoid ArthritisArthritis & Rheumatism, 1971